Skip to main content

Table 2 FDR q-values for the top 15 pathways across different results from GSEA

From: Modification effect of fenofibrate therapy, a longitudinal epigenomic-wide methylation study of triglycerides levels in the GOLDN study

Pathway name Pretreatment
FDR q value
Posttreatment
FDR q value
Modification
FDR q value
KEGG_ENDOMETRIAL_CANCER 0.146 0.023 0.040
KEGG_PATHWAYS_IN_CANCER 0.166 0.059 0.137
KEGG_DORSO_VENTRAL_AXIS_FORMATION 0.182 0.067 0.122
KEGG_ADHERENS_JUNCTION 0.141 0.079 0.139
KEGG_TYPE_II_DIABETES_MELLITUS 0.198 0.079 0.092
KEGG_COLORECTAL_CANCER 0.205 0.078 0.107
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY 0.160 0.081 0.138
KEGG_FOCAL_ADHESION 0.165 0.061 0.153
KEGG_MELANOGENESIS 0.178 0.077 0.139
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION 0.193 0.017 0.156
KEGG_CHRONIC_MYELOID_LEUKEMIA 0.160 0.134 0.133
KEGG_BASAL_CELL_CARCINOMA 0.153 0.055 0.199
KEGG_CALCIUM_SIGNALING_PATHWAY 0.236 0.067 0.133
KEGG_WNT_SIGNALING_PATHWAY 0.230 0.075 0.133
KEGG_NON_SMALL_CELL_LUNG_CANCER 0.289 0.070 0.109
\